Autoimmune diseases (ADs) are now the fastest growing disease category for autologous hematopoietic cell transplantation (aHCT). Despite the evolution of competing biological and targeted therapies...
No takes yet. Share an insight, caveat, or question.
Snowden et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: